Facing the fear - clinical and neural effects of cognitive behavioural and pharmacotherapy in panic disorder with agoraphobia

European Neuropsychopharmacology

Volumn 26, Issue 3, 2016, Pages 431-444

  Liebscher, Carolin ^a   Wittmann, André ^a   Gechter, Johanna ^a   Schlagenhauf, Florian ^a,b   Lueken, Ulrike ^c   Plag, Jens ^a   Straube, Benjamin ^d   Pfleiderer, Bettina ^e   Fehm, Lydia ^f   Gerlach, Alexander L ^g   Kircher, Tilo ^d   Fydrich, Thomas ^f   Deckert, Jürgen ^c   Wittchen, Hans Ulrich ^h   Heinz, Andreas ^a   Arolt, Volker ^e   Ströhle, Andreas ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MAX PLANCK INSTITUTE FOR HUMAN COGNITIVE AND BRAIN SCIENCES   (Germany)

^c UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^d PHILIPPS UNIVERSITY MARBURG   (Germany)

^e UNIVERSITY OF MÜNSTER   (Germany)

^f HUMBOLDT UNIVERSITY   (Germany)

^g UNIVERSITY OF COLOGNE   (Germany)

^h DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Agoraphobia; CBT; FMRI; Panic; SSRI; Westphal Paradigm

Indexed keywords

SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; OXYGEN;

ADULT; AGORAPHOBIA; ANXIETY SENSITIVITY INDEX; ARTICLE; BECK DEPRESSION INVENTORY; BEHAVIOR THERAPY; CLINICAL ASSESSMENT; COGNITIVE THERAPY; CONTROLLED STUDY; FEAR; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HAMILTON ANXIETY SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; PANIC; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SELF REPORT; SYMPTOM; TREATMENT OUTCOME; BLOOD; BRAIN; COMPLICATION; DIAGNOSTIC IMAGING; DRUG EFFECTS; IMAGE PROCESSING; NUCLEAR MAGNETIC RESONANCE IMAGING; PANIC DISORDER; PERSONALITY TEST; PHYSIOLOGY; PSYCHOLOGY; STATISTICS;

AGORAPHOBIA; BRAIN; COGNITIVE THERAPY; FEAR; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; OXYGEN; PANIC DISORDER; PERSONALITY INVENTORY; PSYCHIATRIC STATUS RATING SCALES; SELF REPORT; SEROTONIN UPTAKE INHIBITORS; STATISTICS AS TOPIC; TREATMENT OUTCOME;

EID: 84961797183     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2016.01.004     Document Type: Article

References (43)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2000, American Psychiatric Press, Washington, DC. 4th ed.
2. Bandelow B. Panic and Agoraphobia Scale (PAS) 1997, Hogrefe & Huber, Seattle, WA.
3. Bandelow B., Lichte T., Rudolf S., Wiltink J., Beutel M.E. The diagnosis of and treatment recommendations for anxiety disorders. Dtsch. Arzteblatt Int. 2014, 111:473-480.
4. Bandelow B., Reitt M., Rover C., Michaelis S., Gorlich Y., Wedekind D. Efficacy of treatments for anxiety disorders: a meta-analysis. Int. Clin. Psychopharmacol. 2015, 30:183-192.
5. Beck A.T., Ward C.H., Mendelson M., Mock L., Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry 1961, 4:561-571.
6. Beutel M.E., Stark R., Pan H., Silbersweig D., Dietrich S. Changes of brain activation pre- post short-term psychodynamic inpatient psychotherapy: an fMRI study of panic disorder patients. Psychiatry Res. 2010, 184:96-104.
7. Bradley M.M., Lang P.J. Measuring emotion: the self-assessment Manikin and the Semantic differential. J. Behav. Ther. Exp. Psychiatry 1994, 25:49-59.
8. Chambless D.L., Caputo G.C., Jasin S.E., Gracely E.J., Williams C. The mobility inventory for agoraphobia. Behav. Res. Ther. 1985, 23:35-44.
9. Dresler T., Guhn A., Tupak S.V., Ehlis A.C., Herrmann M.J., Fallgatter A.J., Deckert J., Domschke K. Revise the revised? New dimensions of the neuroanatomical hypothesis of panic disorder. J. Neural Trans. 2013, 120:3-29.
10. Etkin A., Wager T.D. Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. Am. J. Psychiatry 2007, 164:1476-1488.
11. Furmark T., Tillfors M., Marteinsdottir I., Fischer H., Pissiota A., Langstrom B., Fredrikson M. Common changes in cerebral blood flow in patients with social phobia treated with citalopram or cognitive-behavioral therapy. Arch. Gen. Psychiatry 2002, 59:425-433.
12. Gloster A.T., Wittchen H.U., Einsle F., Hofler M., Lang T., Helbig-Lang S., Fydrich T., Fehm L., Hamm A.O., Richter J., Alpers G.W., Gerlach A.L., Strohle A., Kircher T., Deckert J., Zwanzger P., Arolt V. Mechanism of action in CBT (MAC): methods of a multi-center randomized controlled trial in 369 patients with panic disorder and agoraphobia. Eur. Arch. Psychiatry Clin. Neurosci. 2009, 259(Suppl 2):S155-S166.
13. Gloster A.T., Wittchen H.U., Einsle F., Lang T., Helbig-Lang S., Fydrich T., Fehm L., Hamm A.O., Richter J., Alpers G.W., Gerlach A.L., Ströhle A., Kircher T., Deckert J., Zwanzger P., Hofler M., Arolt V. Psychological treatment for panic disorder with agoraphobia: a randomized controlled trial to examine the role of therapist-guided exposure in situ in CBT. J. Consult. Clin. Psychol. 2011, 79:406-420.
14. Gorman J.M., Kent J.M., Sullivan G.M., Coplan J.D. Neuroanatomical hypothesis of panic disorder, revised. Am. J. Psychiatry 2000, 157:493-505.
15. Hamilton M. Diagnosis and rating of anxiety. Br. J. Psychiatry Spec. Publ. 1969, 76-79.
16. Hayano F., Nakamura M., Asami T., Uehara K., Yoshida T., Roppongi T., Otsuka T., Inoue T., Hirayasu Y. Smaller amygdala is associated with anxiety in patients with panic disorder. Psychiatry Clin. Neurosci. 2009, 63:266-276.
17. Hegerl U., Hautzinger M., Mergl R., Kohnen R., Schutze M., Scheunemann W., Allgaier A.K., Coyne J., Henkel V. Effects of pharmacotherapy and psychotherapy in depressed primary-care patients: a randomized, controlled trial including a patients[U+05F3] choice arm. Int. J. Neuropsychopharmacol./Off. Sci. J. Coll. Int. Neuropsychopharmacol. 2010, 13:31-44.
18. Kienast T., Hariri A.R., Schlagenhauf F., Wrase J., Sterzer P., Buchholz H.G., Smolka M.N., Grunder G., Cumming P., Kumakura Y., Bartenstein P., Dolan R.J., Heinz A. Dopamine in amygdala gates limbic processing of aversive stimuli in humans. Nature Neurosci. 2008, 11:1381-1382.
19. Kircher T., Arolt V., Jansen A., Pyka M., Reinhardt I., Kellermann T., Konrad C., Lueken U., Gloster A.T., Gerlach A.L., Strohle A., Wittmann A., Pfleiderer B., Wittchen H.U., Straube B. Effect of cognitive-behavioral therapy on neural correlates of fear conditioning in panic disorder. Biol. Psychiatry 2013, 73:93-101.
20. Linden D.E. How psychotherapy changes the brain--the contribution of functional neuroimaging. Mol. Psychiatry 2006, 11:528-538.
21. Lueken U., Straube B., Konrad C., Wittchen H.U., Ströhle A., Wittmann A., Pfleiderer B., Uhlmann C., Arolt V., Jansen A., Kircher T. Neural substrates of treatment response to cognitive-behavioral therapy in panic disorder with agoraphobia. Am. J. Psychiatry 2013, 170:1345-1355.
22. Lueken U., Straube B., Reinhardt I., Maslowski N.I., Wittchen H.U., Strohle A., Wittmann A., Pfleiderer B., Konrad C., Ewert A., Uhlmann C., Arolt V., Jansen A., Kircher T. Altered top-down and bottom-up processing of fear conditioning in panic disorder with agoraphobia. Psychol. Med. 2014, 44:381-394.
23. Lueken U., Straube B., Wittchen H.-U., Konrad C., Ströhle A., Wittmann A., Pfleiderer B., Arolt V., Kircher T., Deckert J., Reif A. Therapygenetics: anterior cingulate cortex - amygdala coupling is associated with 5-HTTLPR and treatment response in panic disorder and agoraphobia,. J. Neural Trans 2015, 122:135-144.
24. Maldjian J.A., Laurienti P.J., Kraft R.A., Burdette J.H. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. NeuroImage 2003, 19:1233-1239.
25. McHugh R.K., Smits J.A., Otto M.W. Empirically supported treatments for panic disorder. Psychiatr. Clin. North Am. 2009, 32:593-610.
26. Oldfield R.C. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971, 9:97-113.
27. Prasko J., Horacek J., Zalesky R., Kopecek M., Novak T., Paskova B., Skrdlantova L., Belohlavek O., Hoschl C. The change of regional brain metabolism (18FDG PET) in panic disorder during the treatment with cognitive behavioral therapy or antidepressants. Neuro Endocrinol. Lett. 2004, 25:340-348.
28. Pull C.B., Damsa C. Pharmacotherapy of panic disorder. Neuropsychiatr. Dis. Treat. 2008, 4:779-795.
29. Reiss S., Peterson R.A., Gursky D.M., McNally R.J. Anxiety sensitivity, anxiety frequency and the prediction of fearfulness. Behav. Res. Ther. 1986, 24:1-8.
30. Reitan R.M. Validity of the trail making test as an indication of organic brain damage. Percept. Motor Skills 1958, 8:271-276.
31. Roshanaei-Moghaddam B., Pauly M.C., Atkins D.C., Baldwin S.A., Stein M.B., Roy-Byrne P. Relative effects of CBT and pharmacotherapy in depression versus anxiety: is medication somewhat better for depression, and CBT somewhat better for anxiety?. Depression Anxiety 2011, 28:560-567.
32. Sakai Y., Kumano H., Nishikawa M., Sakano Y., Kaiya H., Imabayashi E., Ohnishi T., Matsuda H., Yasuda A., Sato A., Diksic M., Kuboki T. Cerebral glucose metabolism associated with a fear network in panic disorder. Neuroreport 2005, 16:927-931.
33. Schienle A., Schafer A., Stark R., Vaitl D. Long-term effects of cognitive behavior therapy on brain activation in spider phobia. Psychiatry Res. 2009, 172:99-102.
34. Sim H.B., Kang E.H., Yu B.H. Changes in cerebral cortex and limbic brain functions after short-term paroxetine treatment in panic disorder: an [F]FDG-PET pilot study. Psychiatry Investig. 2010, 7:215-219.
35. Straube B., Lueken U., Jansen A., Konrad C., Gloster A.T., Gerlach A.L., Ströhle A., Wittmann A., Pfleiderer B., Gauggel S., Wittchen U., Arolt V., Kircher T. Neural correlates of procedural variants in cognitive-behavioral therapy: a randomized, controlled multicenter FMRI study. Psychother. Psychosom. 2014, 83:222-233.
36. Tewes U. HAWIE-R: Hamburg-Wechsler- Intelligenztest für Erwachsene. Revision 1991; Handbuch und Testanweisung. [Hamburg-Wechsler Intelligence Test for Adults. Revision 1991; Handbook and test instructions] 1991, Hans Huber, Bern, etc.
37. Tzourio-Mazoyer N., Landeau B., Papathanassiou D., Crivello F., Etard O., Delcroix N., Mazoyer B., Joliot M. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. NeuroImage 2002, 15:273-289.
38. van Apeldoorn F.J., Timmerman M.E., Mersch P.P., van Hout W.J., Visser S., van Dyck R., den Boer J.A. A randomized trial of cognitive-behavioral therapy or selective serotonin reuptake inhibitor or both combined for panic disorder with or without agoraphobia: treatment results through 1-year follow-up. J. Clin. Psychiatry 2010, 71:574-586.
39. Wittchen H.U., Jacobi F., Rehm J., Gustavsson A., Svensson M., Jonsson B., Olesen J., Allgulander C., Alonso J., Faravelli C., Fratiglioni L., Jennum P., Lieb R., Maercker A., van Os J., Preisig M., Salvador-Carulla L., Simon R., Steinhausen H.C. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur. Neuropsychopharmacol.: J. Eur. Coll. Neuropsychopharmacol. 2011, 21:655-679.
40. Wittchen H.U., Pfister H. DIA-X Interview. Instruction Manual for the DIA-X Interview 1997, Swets and Zeitlinger, Frankfurt.
41. Wittmann A., Schlagenhauf F., Guhn A., Lueken U., Gaehlsdorf C., Stoy M., Bermpohl F., Fydrich T., Pfleiderer B., Bruhn H., Gerlach A.L., Kircher T., Straube B., Wittchen H.-U., Arolt V., Heinz A., Strohle A. Anticipating agoraphobic situations: the neural correlates of panic disorder with agoraphobia. Psycholog. Med. 2014, 1-12.
42. Wittmann A., Schlagenhauf F., John T., Guhn A., Rehbein H., Siegmund A., Stoy M., Held D., Schulz I., Fehm L., Fydrich T., Heinz A., Bruhn H., Ströhle A. A new paradigm (Westphal-Paradigm) to study the neural correlates of panic disorder with agoraphobia. Eur. Arch. Psychiatry Clin. Neurosci. 2011, 261:185-194.
43. Yang Y., Kircher T., Straube B. The neural correlates of cognitive behavioral therapy: recent progress in the investigation of patients with panic disorder. Behav. Res. Ther. 2014, 62:88-96.